Fosaprepitant
Back to searchMolecule Structure
Scientific Name
Fosaprepitant
Description of the Drug
Fosaprepitant is an antiemetic drug used in combination with other antiemetic agents for the prevention of acute and delayed nausea and vomiting caused by chemotherapy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06717
http://www.drugbank.ca/drugs/DB06717
Brand Name(s)
Ivemend
Company Owner(s)
Apotex Inc, Fresenius Kabi Usa Llc, Msn Laboratories Private Ltd, Mylan Laboratories Ltd, Sandoz Inc, Navinta Llc, Arthur Group Llc, Merck And Co Inc, Eugia Pharma Specialities Ltd, Accord Healthcare Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Neurokinin 1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL249 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL309491 | |
| PharmGKB | PA165958390 | |
| Human Metabolome Database | HMDB0015662 | |
| DrugBank | DB06717 | |
| PubChem: Thomson Pharma | 14887470 | |
| PubChem | 135413538 | |
| Nikkaji | J1.291.580B | |
| DrugCentral | 4470 | |
| ChemicalBook | CB11515191 | |
| Guide to Pharmacology | 7623 | |
| rxnorm | FOSAPREPITANT | FOSAPREPITANT DIMEGLUMINE |
| ChEBI | 64321 | |
| ZINC | ZINC000003939013 |
